FDA Approves a 3rd Vaccine for Emergency Use
posted by Joshua Dungee | March 5, 2021 | In NewsAfter receiving emergency use authorization by the Food and Drug Administration (FDA) local health officials are processing where to send the new COVID-19 vaccination developed by Johnson & Johnson, according to the North Carolina Department of Health and Human Services.
The emergency use authorization allows the Johnson & Johnson vaccination to be administered in the U.S for individuals 18 years of age or older. Of the first 4 million, North Carolina received more than 83,000 doses of the Johnson & Johnson vaccine to spread out across 34 different counties this week. The Johnson & Johnson vaccine only requires one shot and does not need to be stored in extra cold temperatures.
The Johnson & Johnson vaccine was made in partnership with the Janessen Pharmaceuticals and has been proven to be 85 % effective, according to NBC News. No one who received the Johnson & Johnson vaccine had to be hospitalized from COVID-19, nor did anyone die from COVID-19 complications, according to The News & Observer.
The Johnson & Johnson vaccine is made with a very special type of virus and, according to the FDA, that virus is called adenovirus type 26 (Ad26).
This is now the third variant of the vaccine being used by the United States, the other two are made by Pfizer and Moderna.
Photo courtesy of VCU Capital News Service
Leave a Reply
You must be logged in to post a comment.